Status:
COMPLETED
Clinical Investigation of the WaveLight® EX500 Excimer Laser
Lead Sponsor:
Alcon Research
Conditions:
Hyperopia
Hyperopic Astigmatism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to collect efficacy and safety data on the WaveLight EX500 excimer laser system for the correction of hyperopia with and without astigmatism by laser in situ keratomileusi...
Detailed Description
Qualified subjects will receive LASIK treatment in both eyes and be followed for 1 year. Subjects will be asked to attend a total of 9 visits (Screening, Surgery, Day 1, Week 1, Month 1, Month 3, Mont...
Eligibility Criteria
Inclusion
- Key
- Intended to treat bilaterally;
- Hyperopia with or without astigmatism as specified in the protocol;
- Stable vision as specified in the protocol;
- Other protocol-defined inclusion criteria may apply.
- Key
Exclusion
- Glaucoma;
- Cataracts;
- Previous eye surgery;
- Intent to have monovision treatment;
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
April 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 2 2023
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04805593
Start Date
April 28 2021
End Date
May 2 2023
Last Update
August 21 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Durrie Vision
Overland Park, Kansas, United States, 66210
2
Moyes Eye Center
Kansas City, Missouri, United States, 64154
3
Physicians Protocol
Greensboro, North Carolina, United States, 27401
4
Vance Thompson Vision ND
West Fargo, North Dakota, United States, 58078